Fiche société
NeuroDerm Ltd.
Traitements, essais et publications liés.
Traitements2programmes
Essais1liés
Publications3liées
SourceDBlocale
Traitements
2| Molécule | Indication / population | Phase | Objectif | Pays | Résultat |
|---|---|---|---|---|---|
| Levodopa/carbidopa solution for SC administrationIn this Phase I/IIa study, the effect of continuous subcutaneous administration of LD/CD solution (ND0612) on the safety and PK profile of LD will be examined. | Parkinson | Phase 1 | À vérifier | Israel | À vérifier |
| Levodopa/carbidopa solution for SC administrationIn this Phase I/IIa study, the effect of continuous subcutaneous administration of LD/CD solution (ND0612) on the safety and PK profile of LD will be examined. | Parkinson | Phase 1 | À vérifier | Israel | À vérifier |
Essais cliniques
1| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Levodopa/carbidopa solution for SC administration | Parkinson | Phase 1 | NCT01725802 | A Safety, Tolerability, and Plasma Concentration Study of Levodopa/Carbidopa Subcutaneous Solution (ND0612) in Parkinson's Disease (PD) Patients | COMPLETED |
Publications
3| Molécule | Indication / population | Titre | Journal | Date |
|---|---|---|---|---|
| Levodopa/carbidopa solution for SC administration | Isolated extra pontine myelinolysis presenting as acute onset parkinsonism. | BMJ case reports | ||
| Levodopa/carbidopa solution for SC administration | Extrapontine Myelinolysis and Reversible Parkinsonism After Hyponatremia Correction in a Case of Pituitary Adenoma: Hypopituitarism as a Predisposition for Osmotic Demyelination. | World neurosurgery | ||
| Levodopa/carbidopa solution for SC administration | Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease. | Annals of neurology |